113 related articles for article (PubMed ID: 2519544)
1. Marrow purging for autologous bone marrow transplantation.
Combaret V; Favrot MC; Philip T
Targeted Diagn Ther; 1989; 2():137-54. PubMed ID: 2519544
[No Abstract] [Full Text] [Related]
2. Bone marrow purging with etoposide/methylprednisolone in patients undergoing autologous bone marrow transplantation.
Pineiro L; Fay J; Collins R; Herzig G
Prog Clin Biol Res; 1994; 389():17-21. PubMed ID: 7700899
[No Abstract] [Full Text] [Related]
3. Purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma.
Gribben JG; Nadler LM
Important Adv Oncol; 1993; ():139-56. PubMed ID: 8505048
[No Abstract] [Full Text] [Related]
4. Expansion and activation of human natural killer cells as therapy for autologous transplantation.
Miller JS; Verfaillie C; McGlave P
Prog Clin Biol Res; 1994; 389():39-45. PubMed ID: 7700914
[No Abstract] [Full Text] [Related]
5. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Bishop MR; Warkentin PI; Jackson JD; Bayever E; Iversen PL; Whalen VI; Lastovica J; Haines K; Kessinger A
Prog Clin Biol Res; 1994; 389():183-7. PubMed ID: 7700901
[No Abstract] [Full Text] [Related]
6. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
Sieber F; Gaffney DK; Yamazaki T; Qiu K
Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
[No Abstract] [Full Text] [Related]
7. A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow.
Farley TJ; Preti RA; Ahmed T; Ciavarella D
Prog Clin Biol Res; 1994; 389():105-9. PubMed ID: 7535430
[No Abstract] [Full Text] [Related]
8. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
9. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
[No Abstract] [Full Text] [Related]
10. Negative selection and protection of normal progenitor cells for autografting.
Douay L
Bone Marrow Transplant; 1998 Sep; 22(5):423-30. PubMed ID: 9733264
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
[No Abstract] [Full Text] [Related]
12. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
13. New approaches for bone marrow purging.
Beaujean F; Hervé P
Transfus Sci; 1992; 13(4):431-42. PubMed ID: 10150140
[No Abstract] [Full Text] [Related]
14. Autologous bone marrow rescue for patients with acute myelogenous leukemia: purging with hyperthermia and ether lipid in vitro.
Min W; Kim D; Lee J; Park J; Kim C; Kim D
Prog Clin Biol Res; 1994; 389():197-203. PubMed ID: 7700903
[No Abstract] [Full Text] [Related]
15. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Kapelushnik J; Nagler A; Or R; Naparstek E; Cividalli G; Aker M; Mehta J; Mumcuoglu M; Slavin S
Transplant Proc; 1993 Jun; 25(3):2375-6. PubMed ID: 8516934
[No Abstract] [Full Text] [Related]
17. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
18. [Experience with the use of different methods of bone marrow separation and cryopreservation at the bone marrow transplantation centers of the Regional Hospital of the City of Bolzano (Italy) and of the Saint Petersburg Institute of Hematology and Blood Transfusion].
Moiseev SI; Kozer P; Prinot O; Gentelini I; Gritsaev SV; Abdulkadyrov KM
Ter Arkh; 1994; 66(7):21-5. PubMed ID: 7985122
[No Abstract] [Full Text] [Related]
19. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
20. An effective and safe marrow purging strategy using a lethally irradiated killer T cell clone.
Cesano A; Pierson G; Santoli D
Prog Clin Biol Res; 1994; 389():165-73. PubMed ID: 7700898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
